# Acquired Immunodeficiency Syndrome trials: 171 new

Updated November 9, 2026.

171 clinical studies in Acquired Immunodeficiency Syndrome were first posted on ClinicalTrials.gov from November 22, 2024 to November 9, 2026; 18 have an industry sponsor and 121 are recruiting or about to. The newest, NCT07925307, was posted on November 9, 2026: C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV (University of California, San Diego).

## The full list

New Acquired Immunodeficiency Syndrome clinical trials: 171 rows for $8.55, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 7 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/acquired-immunodeficiency-syndrome

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 171
- Industry sponsored: 18
- Recruiting or not yet: 121
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 171, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925307 | C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV | University of California, San Diego | Not applicable | Recruiting | Human Papillomavirus (HPV), HPV Associated Cancers, Cervical Cancer, Human Immunodeficiency Virus (HIV), Cervical... | 750 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925307) |
| November 6, 2026 | NCT07921472 | Cohort of Women Living With HIV-1 and Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | Observational | Recruiting | HIV (Human Immunodeficiency Virus), Pregnancy | 300 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921472) |
| October 29, 2026 | NCT07903441 | Multiple Interventions With Distinct Anti-reservoir Activities in People on Antiretroviral Treatment | Federal University of São Paulo | Phase 2 | Recruiting | HIV - Human Immunodeficiency Virus | 70 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903441) |
| October 28, 2026 | NCT07900750 | Bwelela Easy Study | Washington University School of Medicine | Not applicable | Not yet recruiting | HIV, HIV - Human Immunodeficiency Virus, Treatment Interruption, Reengagement | 1,500 | Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900750) |
| October 23, 2026 | NCT07892664 | Reducing Arterial Inflammation Using Eplerenone and Statins in HIV | Massachusetts General Hospital | Phase 2/3 | Not yet recruiting | HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease | 124 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892664) |
| October 19, 2026 | NCT07881809 | A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 45 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881809) |
| October 19, 2026 | NCT07881575 | Testing a Multi-Level Approach to Reduce Stigma for Women Living With HIV | RTI International | Not applicable | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 680 | Tanzania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881575) |
| October 6, 2026 | NCT07859904 | Study on Retention in Care and on Clinical Chracteristics of HIV-infected Women Treated With Bictegravir/Emtricitabine/Tenofovir... | Ente Ospedaliero Ospedali Galliera | Observational | Not yet recruiting | HIV 1 Infection | 100 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859904) |
| October 1, 2026 | NCT07852611 | Auricular Point Acupressure for Pain | Dan Song | Not applicable | Not yet recruiting | HIV (Human Immunodeficiency Virus), Pain | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852611) |
| October 1, 2026 | NCT07851337 | Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy | ANRS, Emerging Infectious Diseases | Phase 2 | Not yet recruiting | HIV - Human Immunodeficiency Virus | 36 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851337) |
| October 1, 2026 | NCT07851077 | Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care... | City University of New York, School of Public Health | Not applicable | Not yet recruiting | HIV, Mental Health | 3,900 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851077) |
| September 30, 2026 | NCT07849933 | Innate-like and NK Signatures in Chronic-Treated HIV Infection INSTINCT-HIV | Hospices Civils de Lyon | Observational | Not yet recruiting | Human Immunodeficiency Virus Infection (HIV) | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849933) |
| September 25, 2026 | NCT07840651 | Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in Uganda | Makerere University | Not applicable | Not yet recruiting | TB - Tuberculosis, HIV - Human Immunodeficiency Virus | 124 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840651) |
| September 16, 2026 | NCT07821671 | Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study | Emory University | Not applicable | Not yet recruiting | Human Immunodeficiency Virus | 223,165 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821671) |
| September 4, 2026 | NCT07804602 | PositiveLinks for Youth (PL4Y) for Texas | The University of Texas Health Science Center at San Antonio | Not applicable | Not yet recruiting | Human Immunodeficiency Virus, HIV | 600 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804602) |
| September 3, 2026 | NCT07801456 | A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | Cytomegalovirus (CMV), HIV (Human Immunodeficiency Virus) | 12 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801456) |
| August 26, 2026 | NCT07787988 | Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Randomized Trial | University of California, San Francisco | Not applicable | Recruiting | HIV/AIDS, HIV/AIDS Prevention | 560 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787988) |
| August 12, 2026 | NCT07761819 | Effect of Extra Virgin Olive Oil Consumption on the Occurrence of Cardiovascular Events in Population Living With HIV | Fundacion SEIMC-GESIDA | Not applicable | Not yet recruiting | HIV - Human Immunodeficiency Virus | 1,324 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761819) |
| August 12, 2026 | NCT07760324 | CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation | Centre for Infectious Disease Research in Zambia | Observational | Suspended | HIV - Human Immunodeficiency Virus | 151 | Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760324) |
| August 11, 2026 | NCT07756736 | Psilocybin Therapy for Methamphetamine Use Disorder and HIV | Nicky Mehtani, MD, MPH | Phase 2 | Recruiting | Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07756736) |
| August 10, 2026 | NCT07753902 | Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting Conditions | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | Phase 1 | Completed | Human Immunodeficiency Virus (HIV) Infection | 48 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753902) |
| August 6, 2026 | NCT07750834 | Implementation and Assessment of a Medication Therapy Management Program in HIV Patients at High Risk of Adverse Drug Events at Khartoum... | Universiti Sains Malaysia | Not applicable | Completed | HIV Infections | 1,149 | Sudan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750834) |
| August 5, 2026 | NCT07747987 | Improving Management of Recipients of Care With HIV Viremia to Optimize Viral Suppression in Zambia: A Process and Outcome Evaluation | Centre for Infectious Disease Research in Zambia | Not applicable | Completed | HIV - Human Immunodeficiency Virus | 548 | Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747987) |
| August 4, 2026 | NCT07745530 | Platelets Target the Circulating HIV Reservoir: Implications for Immunological Failure | Tourcoing Hospital | Observational | Recruiting | HIV | 90 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745530) |
| July 30, 2026 | NCT07737275 | Screening With Portable X-rays for Rapid Recognition of TB | Columbia University | Not applicable | Recruiting | Tuberculosis (TB), Tuberculosis Infection, Latent, HIV (Human Immunodeficiency Virus) | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737275) |
| July 28, 2026 | NCT07731932 | PNF RCT to Decrease Alcohol Use and Increase HIV Prevention | Vanderbilt University | Not applicable | Not yet recruiting | HIV (Human Immunodeficiency Virus), Alcohol Misuse, STI | 1,350 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731932) |
| July 22, 2026 | NCT07720128 | Advanced HIV Re-engagement in Care | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Advanced HIV Disease | 724 | Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07720128) |
| July 17, 2026 | NCT07711223 | Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus... | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | Phase 1/2 | Recruiting | Infection, Human Immunodeficiency Virus | 660 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711223) |
| July 17, 2026 | NCT07711210 | Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse... | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | Phase 1/2 | Active not recruiting | Infection, Human Immunodeficiency Virus | 12 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711210) |
| July 16, 2026 | NCT07707778 | Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV | National Taiwan University Clinical Trial Center | Phase 4 | Enrolling by invitation | Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease, Dyslipidaemia, Diabetes... | 60 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707778) |
| July 14, 2026 | NCT07703748 | Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir... | FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE | Observational | Active not recruiting | Human Immunodeficiency Virus Infection (HIV), HIV-1 Infection in Adults | 3,346 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07703748) |
| July 13, 2026 | NCT07698600 | A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV | BioNTech SE | Phase 1 | Recruiting | HIV -1 Infection | 126 | South Africa, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07698600) |
| July 13, 2026 | NCT07698574 | Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency | Beijing University of Chinese Medicine | Not applicable | Not yet recruiting | HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder... | 240 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07698574) |
| July 13, 2026 | NCT07698548 | Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang Deficiency | Beijing University of Chinese Medicine | Not applicable | Not yet recruiting | HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder... | 240 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07698548) |
| July 10, 2026 | NCT07696169 | Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers | Shenzhen Third People's Hospital | Observational | Not yet recruiting | HIV (Human Immunodeficiency Virus), AIDS, Kaposi Sarcoma (KS), Lymphoma, AIDS-Related Malignancy, Lung Cancer in the... | 1,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696169) |
| July 8, 2026 | NCT07691424 | Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France | University Hospital, Clermont-Ferrand | Observational | Not yet recruiting | HIV - Human Immunodeficiency Virus, Socio-economic Status, Migrants | 150 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691424) |
| June 29, 2026 | NCT07673965 | Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in... | University of Witwatersrand, South Africa | Phase 4 | Not yet recruiting | HIV (Human Immunodeficiency Virus), Sleep | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673965) |
| June 23, 2026 | NCT07662161 | Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study) | Instituto Mexicano del Seguro Social | Observational | Not yet recruiting | HIV - Human Immunodeficiency Virus | 384 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662161) |
| June 22, 2026 | NCT07658976 | Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy | HIV Prevention Trials Network | Phase 3 | Not yet recruiting | HIV Infection, Sexually Transmitted Infection | 400 | Argentina, Brazil, Peru, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07658976) |
| June 17, 2026 | NCT07652918 | Comparison of Acceptance and Commitment Therapy and Cognitive Behavior Therapy: Managing Psychological Distress and Its Multifaceted Impact... | Sadia Batool | Not applicable | Active not recruiting | HIV - Human Immunodeficiency Virus, Psychological Distress | 72 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652918) |
| June 12, 2026 | NCT07645378 | Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa | Fred Hutchinson Cancer Center | Not applicable | Recruiting | HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer, Cervical Neoplasia | 200 | South Africa | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645378) |
| June 12, 2026 | NCT07645352 | Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in... | Fred Hutchinson Cancer Center | Not applicable | Recruiting | HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer, Cervical Neoplasia | 300 | Zimbabwe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645352) |
| June 11, 2026 | NCT07640880 | Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV | Yinzhong Shen | Observational | Not yet recruiting | MASLD, HIV (Human Immunodeficiency Virus) | 120 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07640880) |
| June 9, 2026 | NCT07636928 | Mass Balance and Absolute Oral Bioavailability of \[14C\]VH4524184 | ViiV Healthcare | Phase 1 | Recruiting | HIV Infections | 9 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636928) |
| June 9, 2026 | NCT07635992 | A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone... | First Affiliated Hospital of Zhejiang University | Phase 1 | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 18 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07635992) |
| June 5, 2026 | NCT07631104 | Improving the HIV Care Continuum With mHealth Technology | University of South Carolina | Not applicable | Not yet recruiting | HIV - Human Immunodeficiency Virus, HIV Antiretroviral Therapy (ART) Adherence, mHealth Application, mHealth... | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07631104) |
| June 2, 2026 | NCT07621224 | Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country | Biogipuzkoa Health Research Institute | Observational | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 12,546 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621224) |
| June 2, 2026 | NCT07620197 | Income Generation, Food and Nutrient Security for Improved Livelihoods and Health Outcomes Among HIV-Positive, Kenya | Maseno University | Not applicable | Completed | HIV (Human Immunodeficiency Virus), Malnutrition | 64 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620197) |
| May 22, 2026 | NCT07600775 | A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019) | Merck Sharp & Dohme LLC | Phase 1 | Not yet recruiting | Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | 14 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600775) |
| May 12, 2026 | NCT07581600 | ComBaCaL HIV Prevention TwiCs | University Hospital, Basel, Switzerland | Not applicable | Withdrawn | Human Immunodeficiency Virus (HIV) | 0 | Lesotho, Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581600) |
| May 12, 2026 | NCT07579247 | Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS | Shanghai Public Health Clinical Center | Phase 1/2 | Not yet recruiting | HIV, AIDS, Immune Checkpoint Inhibitors, Refractory Opportunistic Infection | 50 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07579247) |
| May 11, 2026 | NCT07577986 | A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir | First Affiliated Hospital of Zhejiang University | Phase 1/2 | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 20 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577986) |
| May 8, 2026 | NCT07576842 | C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV | University of California, San Diego | Not applicable | Not yet recruiting | Human Papillomavirus (HPV), HPV Associated Cancers, Cervical Cancer, Human Immunodeficiency Virus (HIV), Cervical... | 750 | Botswana | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576842) |
| May 4, 2026 | NCT07565623 | Prevention of AIDS With Opportunistic Infection Paradoxical IRIS | Shanghai Public Health Clinical Center | Not applicable | Not yet recruiting | HIV (Human Immunodeficiency Virus), IRIS | 131 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565623) |
| April 30, 2026 | NCT07560046 | Combating Related Epidemics in HCV | Duke University | Phase 4 | Not yet recruiting | HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV) | 1,280 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560046) |
| April 28, 2026 | NCT07553312 | Clinic-Community Bridge to Improve Health Outcomes for Abused Women Living With HIV/AIDS | Johns Hopkins University | Observational | Enrolling by invitation | Adult Women Living With HIV/AIDS, Intimate Partner Violence | 450 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553312) |
| April 27, 2026 | NCT07553052 | Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts | Universitas Sebelas Maret | Not applicable | Completed | Human Immunodeficiency Virus (HIV) | 20 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553052) |
| April 27, 2026 | NCT07552038 | Dental Management of Patients With HIV in Pays de la Loire | Nantes University Hospital | Observational | Recruiting | HIV Infection, Acquired Immune Deficiency Syndrome, Oral Health Care | 5,603 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07552038) |
| April 21, 2026 | NCT07541131 | Lower Intersecting HIV-related Stigmas to Facilitate Treatment as Prevention (LIFT) | University of California, San Diego | Not applicable | Enrolling by invitation | Stigma, Social, Drug Abuse Illicit, HIV (Human Immunodeficiency Virus) | 80 | Kyrgyzstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07541131) |
| April 15, 2026 | NCT07530198 | HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong | Immuno Cure Holding (HK) Limited | Phase 1 | Recruiting | Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection | 22 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07530198) |
| April 14, 2026 | NCT07526948 | Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV | Albert Einstein College of Medicine | Phase 4 | Not yet recruiting | Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related... | 62 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526948) |
| April 13, 2026 | NCT07525544 | A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants | ViiV Healthcare | Phase 1 | Recruiting | HIV Infections | 214 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07525544) |
| April 9, 2026 | NCT07520188 | C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States | UNC Lineberger Comprehensive Cancer Center | Observational | Not yet recruiting | Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Cervical Cancer, Cervical Precancer | 3,500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07520188) |
| April 9, 2026 | NCT07519538 | Southern Sichuan HIV Cohort Study Protocol | Southwest Medical University | Observational | Active not recruiting | HIV - Human Immunodeficiency Virus | 10 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07519538) |
| April 8, 2026 | NCT07516912 | Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland | University of Zurich | Observational | Not yet recruiting | HIV (Human Immunodeficiency Virus), Chlamydia, Gonorrhea, Syphilis, HCV | 1,800 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07516912) |
| April 8, 2026 | NCT07516691 | Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients for Access to a Preventive Sexual Health... | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | HIV | 250 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07516691) |
| March 30, 2026 | NCT07501624 | Engaging Pharmacists to Advance Tobacco Treatment Service Delivery | Medical University of South Carolina | Not applicable | Enrolling by invitation | Smoking Cessation, Tobacco Use Disorder, Smoking, HIV, AIDS, Pharmacy | 172 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501624) |
| March 27, 2026 | NCT07495059 | Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care | University of California, Los Angeles | Not applicable | Recruiting | HIV (Human Immunodeficiency Virus), Continuum of Care, Stigma | 80 | Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495059) |
| March 23, 2026 | NCT07487350 | Recurrent Visceral Leishmaniasis in HIV Co-Infection | Institute of Tropical Medicine, Belgium | Observational | Recruiting | Hiv, Visceral Leishmaniasis | 20 | Ethiopia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07487350) |
| March 20, 2026 | NCT07485374 | Attitudes of Dental Students Towards HIV+ Patients: a Multi-center Survey Among Italian Universities | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 480 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485374) |
| March 17, 2026 | NCT07476339 | REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE | CAN Community Health | Phase 4 | Recruiting | HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV, HIV 1 Infection | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476339) |
| March 12, 2026 | NCT07468695 | Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya | Fred Hutchinson Cancer Center | Not applicable | Recruiting | HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer | 300 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468695) |
| March 12, 2026 | NCT07468487 | Evaluation of the Effectiveness of the HPV Education Program Applied to Women | Okan University | Not applicable | Completed | HIV (Human Immunodeficiency Virus) | 84 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468487) |
| March 12, 2026 | NCT07466836 | The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV | Tyson Perez, DC, PhD | Not applicable | Active not recruiting | Human Immunodeficiency Virus (HIV) | 10 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07466836) |
| March 10, 2026 | NCT07461350 | Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV | University of California, San Francisco | Observational | Enrolling by invitation | HIV (Human Immunodeficiency Virus) | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07461350) |
| March 9, 2026 | NCT07459218 | IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania | Duke University | Not applicable | Not yet recruiting | HIV - Human Immunodeficiency Virus, Suicide Prevention | 600 | Tanzania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07459218) |
| March 3, 2026 | NCT07446764 | Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care | My Brother's Keeper, Inc. | Not applicable | Not yet recruiting | HIV, STDs | 700 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07446764) |
| February 20, 2026 | NCT07423364 | Evaluation of A Reproductive Health Education Program in Women Living With HIV | Okan University | Not applicable | Completed | HIV (Human Immunodeficiency Virus) | 60 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07423364) |
| February 18, 2026 | NCT07418385 | Voluntary HIV Screening in the General Population in France | Université de Reims Champagne-Ardenne | Observational | Recruiting | Human Immunodeficiency Virus (HIV) | 1,000 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07418385) |
| February 12, 2026 | NCT07406490 | Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record... | University of Florida | Observational | Not yet recruiting | Hepatitis C Virus (HCV), Hepatitis C Virus (HCV) Infection, HIV (Human Immunodeficiency Virus) | 6,466 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07406490) |
| February 6, 2026 | NCT07393659 | A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for... | ViiV Healthcare | Phase 3 | Recruiting | HIV Infections | 181 | South Africa | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07393659) |
| February 5, 2026 | NCT07390916 | Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda | Fred Hutchinson Cancer Center | Not applicable | Recruiting | HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer | 300 | Rwanda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390916) |
| February 5, 2026 | NCT07388979 | MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo | Gardiens de Vies | Observational | Not yet recruiting | HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus), Hepatitis C Virus (HCV), Syphilis, Mother-to-Child... | 7,500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388979) |
| February 5, 2026 | NCT07388394 | Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75 | Centre Hospitalier Universitaire de Nice | Not applicable | Recruiting | Virus-HIV | 136 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388394) |
| February 3, 2026 | NCT07384624 | Combining Latency Reversing Agents to Address the HIV Reservoir | Erasmus Medical Center | Phase 1/2 | Not yet recruiting | HIV (Human Immunodeficiency Virus), HIV -1 Infection | 30 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07384624) |
| January 27, 2026 | NCT07370649 | Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study | Pomeranian Medical University Szczecin | Observational | Recruiting | Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection, Virologically... | 250 | Czechia, Germany, Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07370649) |
| January 16, 2026 | NCT07346508 | Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A... | KC Care Health Center | Not applicable | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 250 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07346508) |
| January 14, 2026 | NCT07339189 | HIV Suicide Prevention With AI-DBT | Rutgers, The State University of New Jersey | Not applicable | Recruiting | Suicidal Ideation and Behavior, HIV, AIDS (Acquired Immune Deficiency Syndrome) | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07339189) |
| January 13, 2026 | NCT07336797 | Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy | Abdelrahman Mahmoud | Phase 2 | Recruiting | Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus) | 66 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336797) |
| December 31, 2025 | NCT07312266 | Questioning the Epidemiology of Asymptomatic TB | Barcelona Institute for Global Health | Observational | Recruiting | Tuberculosis, Tuberculosis (TB), HIV, HIV (Human Immunodeficiency Virus) | 6,770 | Mozambique | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312266) |
| December 23, 2025 | NCT07298785 | Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study | University of California, San Francisco | Not applicable | Completed | HIV/AIDS | 60 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298785) |
| December 18, 2025 | NCT07292792 | The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services | University of Texas Southwestern Medical Center | Observational | Recruiting | HIV Disease, HIV Prevention | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292792) |
| December 12, 2025 | NCT07279376 | Evaluating an Algorithm-Based Implementation Strategy to Improve HIV Care Outcomes | Hunter College of City University of New York | Not applicable | Enrolling by invitation | HIV (Human Immunodeficiency Virus) | 2,600 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07279376) |
| December 12, 2025 | NCT07278453 | TB SCReening Improves Preventive Therapy Uptake in Pregnant Women With HIV | University of California, San Francisco | Not applicable | Not yet recruiting | Pregnant HIV Positive Women, HIV, Tuberculosis (TB) | 1,500 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07278453) |
| December 5, 2025 | NCT07266831 | A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) | Merck Sharp & Dohme LLC | Phase 2/3 | Recruiting | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | 570 | Argentina, Canada, Chile, France, Guatemala, Mexico, South Africa, Spain... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266831) |
| November 19, 2025 | NCT07236905 | Improving Access to HIV Testing for Children in Uganda | University of California, San Francisco | Not applicable | Active not recruiting | HIV (Human Immunodeficiency Virus) | 400 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07236905) |
| November 10, 2025 | NCT07226128 | The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV | Indiana University | Not applicable | Recruiting | HIV, Depression in Adults, Insulin Resistance, Cognitive Behavior Therapy | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07226128) |
| October 27, 2025 | NCT07221201 | Integrating Project YES! With WHO-Endorsed Mental Health Approaches Among Youth Living With HIV | Johns Hopkins Bloomberg School of Public Health | Not applicable | Completed | HIV - Human Immunodeficiency Virus, Mental Health, Anxiety, Depression in Adolescence, Stigma | 323 | Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07221201) |
| October 27, 2025 | NCT07221123 | Boosting Olfactory and Sensory Training Study (BOOST) | University of Alabama at Birmingham | Phase 2 | Recruiting | HIV (Human Immunodeficiency Virus) | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07221123) |
| October 22, 2025 | NCT07219862 | Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization | Keck School of Medicine of USC | Not applicable | Not yet recruiting | HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS), Antiretroviral Therapy, Highly Active... | 250 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07219862) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| University of California, San Francisco | 7 | August 26, 2026 |
| Merck Sharp & Dohme LLC | 6 | May 22, 2026 |
| Fred Hutchinson Cancer Center | 5 | June 12, 2026 |
| ViiV Healthcare | 5 | June 9, 2026 |
| University of California, San Diego | 4 | November 9, 2026 |
| Jiangsu Aidea Pharmaceutical Group Co., Ltd. | 4 | August 10, 2026 |
| Columbia University | 4 | July 30, 2026 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 | October 19, 2026 |
| University of Alabama at Birmingham | 3 | July 22, 2026 |
| Johns Hopkins University | 3 | April 28, 2026 |
| Indiana University | 3 | November 10, 2025 |
| Yale University | 3 | July 8, 2025 |
| Federal University of São Paulo | 2 | October 29, 2026 |
| Washington University School of Medicine | 2 | October 28, 2026 |
| Emory University | 2 | September 16, 2026 |
| Centre for Infectious Disease Research in Zambia | 2 | August 12, 2026 |
| National Taiwan University Clinical Trial Center | 2 | July 16, 2026 |
| Beijing University of Chinese Medicine | 2 | July 13, 2026 |
| First Affiliated Hospital of Zhejiang University | 2 | June 9, 2026 |
| Shanghai Public Health Clinical Center | 2 | May 12, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 87 | November 9, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 37 | November 6, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 13 | September 3, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 12 | October 29, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 8 | July 16, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 6 | July 17, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 5 | June 22, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 2 | October 23, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 1 | September 19, 2025 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 53 | October 23, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 11 | November 6, 2026 |
| [Uganda](https://specstream.ai/data/clinical-trials/country/uganda) | 11 | September 25, 2026 |
| [Kenya](https://specstream.ai/data/clinical-trials/country/kenya) | 10 | November 9, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 10 | August 10, 2026 |
| [South Africa](https://specstream.ai/data/clinical-trials/country/south-africa) | 9 | July 13, 2026 |
| [Zambia](https://specstream.ai/data/clinical-trials/country/zambia) | 6 | October 28, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 6 | December 5, 2025 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 5 | October 29, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 5 | August 12, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 4 | October 6, 2026 |
| [Peru](https://specstream.ai/data/clinical-trials/country/peru) | 4 | June 22, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 4 | June 9, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 3 | June 23, 2026 |
| [Argentina](https://specstream.ai/data/clinical-trials/country/argentina) | 3 | June 22, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 3 | May 12, 2026 |
| [Vietnam](https://specstream.ai/data/clinical-trials/country/vietnam) | 3 | March 27, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 3 | March 12, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 3 | July 8, 2025 |
| [Tanzania](https://specstream.ai/data/clinical-trials/country/tanzania) | 2 | October 19, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 2 | July 16, 2026 |
| [Indonesia](https://specstream.ai/data/clinical-trials/country/indonesia) | 2 | April 27, 2026 |
| Kyrgyzstan | 2 | April 21, 2026 |
| [Ethiopia](https://specstream.ai/data/clinical-trials/country/ethiopia) | 2 | March 23, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 2 | January 27, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).